IMCC vs MEHA

IM Cannabis Corp. vs Functional Brands, Inc. — Valuation Comparison 2026

IMCC

Medicinal Chemicals & Botanical Products
IM Cannabis Corp.
Quality
5.4
out of 10
Value Trap
12
SAFE
Price
$0.29
Last close
Models
4/13
Active
VS

MEHA

Medicinal Chemicals & Botanical Products
Functional Brands, Inc.
Quality
4.7
out of 10
Value Trap
Price
$0.08
Last close
Models
7/13
Active

Model-by-Model Comparison

ModelType IMCC Fair ValueIMCC Upside MEHA Fair ValueMEHA Upside
Bayesian DCF Intrinsic $0.23 +182.2%
Earnings Power Value Intrinsic $1.11 +282.0%
EROIC Spread Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Markov DDM Intrinsic $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $0.29 +0.4% $0.18 +117.3%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
RCMH-DCF Intrinsic $0.46 +457.0%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for IMCC vs MEHA — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

IMCC vs MEHA — Which Stock Is More Undervalued?

IMCC scores higher with a 5.4/10 quality rating vs MEHA's 4.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing IM Cannabis Corp. (IMCC) and Functional Brands, Inc. (MEHA) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

IMCC currently trades at $0.29 with a QOC of 5.4/10, while MEHA trades at $0.08 with a QOC of 4.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).